UAB "Imunovakcina" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
0 |
0 |
47,504 |
-47,504 |
-47,504 |
- |
- |
-46,944 |
70,409 |
0 |
23,465 |
2023 |
---|
85,770 |
42,251 |
19,741 |
19,741 |
9,725 |
41.41 |
23.02 |
-27,203 |
60,111 |
3,000 |
29,908 |
2024 |
---|
150,982 |
50,327 |
71,977 |
70,488 |
23,496 |
49.71 |
46.69 |
43,285 |
106,717 |
3,000 |
148,002 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
150,982 €76 % *
Sales per employee (€)
50,327 €19 % *
Profit before tax (€)
71,977 €265 % *
Net Profit (€)
70,488 €257 % *
Profit per employee (€)
23,496 €142 % *
Total profitability (%)
49.71 %20.04 % *
Net profitability (%)
46.69 %102.82 % *
Equity (€)
43,285 €259 % *
Amounts Payable And Liabilities (€)
106,717 €78 % *
Non-current Assets (€)
3,000 €0 % *
CurrentAssets (€)
148,002 €395 % *